➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Dow
Colorcon
McKesson
Merck

Last Updated: April 12, 2021

DrugPatentWatch Database Preview

Suppliers and packages for biologic ingredient: obinutuzumab

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Suppliers and packages for biologic ingredient: obinutuzumab

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities
Applicant Tradename Biologic Ingredient Dosage BLA NDA/ANDA Supplier Package Code Package
Genentech GAZYVA obinutuzumab INJECTABLE;INJECTION 125486 BLA Genentech, Inc. 50242-070-01 1 VIAL, SINGLE-USE in 1 CARTON (50242-070-01) > 40 mL in 1 VIAL, SINGLE-USE
Genentech GAZYVA obinutuzumab INJECTABLE;INJECTION 125486 BLA Genentech, Inc. 50242-070-86 1 VIAL, SINGLE-USE in 1 CARTON (50242-070-86) > 40 mL in 1 VIAL, SINGLE-USE
>Applicant >Tradename >Biologic Ingredient >Dosage >BLA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Mallinckrodt
Merck
Baxter
Moodys